Sana Fatima
India
Review Article
Efficacy of Spirulina (Tahlab) in Patients of Type 2 Diabetes Mellitus (Ziabetus Shakri) - A Randomized Controlled Trial
Author(s): Anzar Alam, Siddiqui Quamri, Sana Fatima, Mariyam Roqaiya and Zaheer AhmadAnzar Alam, Siddiqui Quamri, Sana Fatima, Mariyam Roqaiya and Zaheer Ahmad
Aims: Diabetes mellitus (DM) (Ziabetus Shakri) is a common metabolic disease affecting 150,000,000 people worldwide. Despite the recent advancements in management of Diabetes its relative co-morbidities and mortality is ever increasing globally. Unani scholars had claimed the effectiveness of several anti-diabetic drugs in the classical texts in the management of DM, but it lacks scientific documentation. Hence, a clinical trial was contemplated to evaluate the efficacy of test drug Tahlab (Spirulina) in patients of type 2 DM.
Methods: The study was a single blind randomized standard control conducted on 40 patients of type 2 DM. 30 subjects were allocated to test and 10 to control group. Test group received 7 grams of Tahlab powder twice a day, and control group received Metformin (500 mg) 1 tablet twice a day for a period of .. View More»
